Navigation Links
AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting

of BPH in the major pharmaceutical markets was estimated at 56 million men and is expected to increase to 65 million cases by 2014. The BPH market is a significant market, with current annual sales of more than $2.6 billion.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aeternazentaris.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticipates", "intends", "plans", "expects", "estimates", "will," "may", "should", "approximately", and the negative or other variations of those terms or comparable terminology, are forward-looking statements. Such statements reflect management's current views, intentions, strategies and plans and are based on certain assumptions.

Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the ability of AEterna Zentaris to implement its business strategies, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of AEterna Zentaris to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities co
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/4/2015)...  In an effort to raise awareness and the ... DentaQuest established the Health Equity Hero Awards to celebrate ... More than 83 million people in ... care. These barriers are most significant for those who ... language, health literacy or geographic isolation.   "Connecting ...
(Date:5/4/2015)... -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... company as Vice President, Medical Affairs. ... Aurora to the Neurocrine team as our Vice ... and Chief Executive Officer of Neurocrine Biosciences. "Bill,s experience ... with his extensive network and influence with psychiatric and ...
(Date:5/4/2015)... 2015 Microbrush International, a leading developer, producer ... restorative procedures, today announced the acquisition of DentiSmart ... sectional matrix system used in dental restorative procedures. ... opportunity to add DentiSmart to our growing portfolio ... VP and General Manager of Microbrush. "DentiSmart,s products ...
Breaking Medicine Technology:DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 2DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 3DentaQuest Honors Seven Oral Health Leaders As Health Equity Heroes With Inaugural National Award 4Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" ... the U.S. and China, commented today on the ruling this ... from funding research involving human embryonic stem cells.  In issuing ... first passed in 1996 prohibiting federal money for research where ...
... KemPharm, Inc. announced today that it has received a ... Trademark Office (USPTO) for its patent application entitled "Non-Standard ... and Using the Same", U.S. Patent No. 7,776,917 B2. ... No. 7,772,222, provides broad protection of the Company,s Ligand ...
Cached Medicine Technology:NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research 2NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research 3KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology 2KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology 3
(Date:5/4/2015)... Jersey (PRWEB) May 04, 2015 Parlin dentist, ... give a chance to more youths to participate and win ... youths in her area to do good deeds and share ... intends to empower their minds and teach them to be ... is accessible to any youth 18 years of age and ...
(Date:5/4/2015)... May 05, 2015 The National ... Hommes as a 2015-2016 inductee into its VIP ... this prestigious distinction for leadership in business. NAPW is ... boasting more than 700,000 members and over 200 operating ... this important honor,” says NAPW President Star Jones. “Her ...
(Date:5/4/2015)... 05, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in healthcare. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor,” says NAPW President Star Jones. “Her perseverance, ...
(Date:5/4/2015)... 2015 Global Vision, the industry ... today announced that it will showcase Proofware at ... Center, in Nashville Tennessee, May 04 and May ... true all-in-one we-based packaging inspection suite, giving enterprise-wide ... of their brand copy and artwork. Proofware offers ...
(Date:5/4/2015)... Hollywood, California (PRWEB) May 04, 2015 ... of holistic treatment for substance absue, Per Wickstrom, the ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... the Stardust Penthouse on the top floor of the ... Durkin, Los Angeles’ top producer of sustainable product placement ...
Breaking Medicine News(10 mins):Health News:10 More Days To Enter Good Deed Contest 2Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2
... health benefits of anti-oxidants, more specifically Vitamin E has ... ,Everyday, a number of studies are studies are being ... has warned that under certain circumstances, the even the ... development of cardiovascular disease, cancer and other disorders. ...
... New South Wales have discovered that temporary injury ... fever// could lead to chronic fatigue syndrome (CFS). ... regions of the brain that play a critical role ... glandular fever infection could damage the above-mentioned regions of ...
... regarding an appeal by health officials, requesting the withdrawal of ... Lawyers who are currently handling the case of this severely ... poor and that doctors should be allowed to let him ... treating physicians have not been revealed due to controversies surrounding ...
... Avastin, a cancer drug may cause trigger a rare ... in the New England Journal of Medicine. ... their 50s treated with Avastin developed reversible posterior leukoencephalopathy ... complications. Doctors said that both the patients have recovered. ...
... to the study it was found that GlaxoSmithKline Plc ... against middle-ear infections in infants// said that the vaccine ... maker. ,Roman Prymula, who led the study ... further tests are necessary before the vaccine hits the ...
... comes the news that a stroll followed by a glass of ... individual.// ,This is in the direction of efforts by the ... non-pharmaceutical means to maintain muscle function and quality of life in ... to make athletes out of the elderly, but to increase our ...
Cached Medicine News:Health News:Vitamin E Can Lead To Heart Disease And Cancer 2Health News:Brain Injury, A Consequence Of Glandular Fever Could Trigger Fatigue Syndrome 2Health News:Life Or Death: Parents Await High Court Judgment 2
Solid 14 mm blades. Dull finish....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Speculum with malleable plate to support flap during ablation of thestromal bed....
Medicine Products: